FDA Withholds Antibiotic Approval, Asks For More Tests

Law360, New York (October 23, 2006, 12:00 AM EDT) -- The U.S. Food and Drug Administration has refused to allow Replidyne Inc. and Forest Laboratories Inc. to market an oral antibiotic and has requested further testing, the companies said Monday.

The companies said that the FDA issued a non-approvable letter for the new drug application for oral antibiotic faropenem medoxomil.

“In its letter the FDA did not raise any safety concerns or chemistry, manufacturing or controls issues related to the product,” the companies said. “Replidyne and Forest intend to discuss the clinical plans with the FDA...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.